engormix
search
search
We will be present at:
October 9, 2019 to October 11, 2019
Lima, Lima, Peru
Umberto Calderon
Umberto Calderon
Lima, Lima, Peru

Amoxi-Tabs C® 250 Amoxicillin Antibiotic for veterinary use

Amoxi-Tabs C® 250

Tablet Oral

Broad-spectrum antibiotic with bacterial resistance inhibitor

Formulation

Amoxicillin base 200 mg, clavulanic acid 50 mg; excipients q.s. ad 1 tablet.

Indications

For the treatment of periodontal infections caused by susceptible strains (aerobic and anaerobic bacterias). Treatment of skin and soft tissues infections caused by susceptible species of Staphylococcus spp. E. coli, Pasteurella spp. and Streptococcus spp. Treatment of respiratory tract and urinary tract infections, including those caused by susceptible species of E. coli. Osteomyelitis treatment and other bacterial complications susceptible to amoxicillin.

Dosage and Administration

1 tablet/16 kg every 8 - 12 hours for at least 3 days. Administer through oral route.

Commercial Presentation

Box x 10 tablets , Box x 50 tablets ,




Additional information
AMOXI-TABS C®-250
PDF Download PDF
Amoxi-Tabs C® 250